Strategic CRM implementation elevates client service delivery across complex project lifecycles We can now easily track ...

UCB obtains worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager (TCE) antibody, targeting B cell-related autoimmune diseasesDeal ...

FleetDomain’s Fleet Management Information System addresses the challenges and risks associated with fleet management on one ...

Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific ...

ESA’s Jupiter Icy Moons Explorer (JUICE) that was launched in 2023 will take about 8 years to arrive at the jovian system after several gravity assists. Credit: Space.com | animation courtesy: ESA / A ...

Antengene, UCB sign global exclusive license agreement to develop, manufacture and commercialize ATG-201: Hong Kong Friday, March 6, 2026, 14:00 Hrs [IST] Antengene Corporation Li ...

Inflight connectivity is evolving from a luxury to a fundamental passenger expectation, transforming the aircraft into a ...

Belgium’s largest drugmaker UCB and Hong Kong based biotech Antengene have entered into an agreement that grants UCB a ...

I had already banged up my knee pretty badly--a hairline fracture in my tibia left me pain that would follow me for years. By the time I was 26, the pain was still there and I never thought it would ...

Many private security companies have been using smartphones and apps as simple as WhatsApp to scan vehicle discs and licence ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...

SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte ...